PT - JOURNAL ARTICLE AU - Evangelista, Heitor AU - Amaral, Cesar AU - Porto, Luís Cristóvão AU - Gonçalves, Sergio J. AU - Sodré, Eduardo Delfino AU - Nogueira, Juliana AU - dos Santos, Angela M.G. AU - Cataldo, Marcio TI - Modeling the initial phase of SARS-CoV-2 deposition in the respiratory tract mimicked by the <sup>11</sup>C radionuclide AID - 10.1101/2020.07.27.20156836 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.27.20156836 4099 - http://medrxiv.org/content/early/2020/07/29/2020.07.27.20156836.short 4100 - http://medrxiv.org/content/early/2020/07/29/2020.07.27.20156836.full AB - The knowledge on the deposition and retention of the viral particle of SARS-CoV-2 in the respiratory tract during the very initial intake from the ambient air is of prime importance to understand the infectious process and COVID-19 initial symptoms. To give some light on that, we propose to use a modified version of a widely tested lung deposition model developed by the ICRP, in the context of the ICRP Publication 66, that provides deposition patterns of microparticles in different lung compartments. In the model, we mimicked the “environmental decay” of the virus, determined by controlled experiments related to normal speeches, by the radionuclide 11C that presents comparable decay rates. Our results confirm clinical observations on the high virus retentions observed in the extrathoracic region and the lesser fraction on the alveolar section (in the order of 5), which relevance is a subject to be investigated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no funding for this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The use of COVID-19 data was approved by the Ethics in Research Committee of the Pedro Ernesto University Hospital under the project entitled Epidemiological, laboratorial, and clinical profile of the COVID-19 pandemic of patients treated at Rio de Janeiro State University (UERJ) (CAAE: 30135320.0.0000.5259). All COVID-19 typing data were de-identified prior to the analysis and available for the authors uniquely as totals, as presented on Table 2.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used to generate the results presented herein are provided in the supplementary material.